Latest Articles about ABMD

BSX and ABMD Highlight Increased Insider Buying in the Medical Technology Sector

Monica Wolfe — Tue, 14 May 2013 18:03:57 Z

In the past week we saw an increase in insider buying coming from the health care industry. Last week GuruFocus reported 31 different insider buys coming from 19 different health care-based

HMA Matches Earnings, Misses Rev Est. - Analyst Blog

Zacks Equity Research — Mon, 06 May 2013 22:20:01 Z

Health Management Associates ( HMA ), a leading operator of general acute care hospitals, reported first quarter 2013 adjusted (excluding one-time expenses other than stock-based

Zacks #1 Rank Additions for Monday - Tale of the Tape

Zacks Equity Research — Mon, 06 May 2013 17:27:22 Z

Here are 5 stocks added to the Zacks #1 Rank ("strong buy") List today: ABIOMED, Inc ( ABMD ) American Vanguard Corp. ( AVD ) Atlatsa Resources Corp (USA) ( ATL )

Thoratec Misses Earnings and Rev Est - Analyst Blog

Zacks Equity Research — Mon, 06 May 2013 17:26:08 Z

Thoratec Corp. ( THOR ) reported first-quarter 2013 adjusted (excluding one-time items other than stock-based compensation expenses) earnings per share of 34 cents missing the Zacks

MWI Vet Earnings Beat, Sales Miss - Analyst Blog

Zacks Equity Research — Fri, 03 May 2013 20:44:45 Z

MWI Veterinary Supply ( MWIV ) reported second-quarter fiscal 2013 earnings per share (EPS) of $1.19, up 4.4% on a year-over-year basis. The result also surpassed the Zacks Consensus

Abiomed Earnings Beat in 4Q - Analyst Blog

Zacks Equity Research — Fri, 03 May 2013 18:31:52 Z

Abiomed Inc. 's ( ABMD ) fourth-quarter fiscal 2013 earnings per share (EPS) of 9 cents beat the Zacks Consensus Estimate of 7 cents by 28.6%. The Massachusetts.-based company registered a

Masimo Matches Earnings Est. - Analyst Blog

Zacks Equity Research — Fri, 03 May 2013 17:32:33 Z

Masimo Corporation ( MASI ), a leader in non-invasive monitoring technology for patient care, recorded first quarter 2013 earnings per share of 28 cents thereby matching the Zacks Consensus

Dismal Earnings Miss by Omnicell - Analyst Blog

Zacks Equity Research — Fri, 03 May 2013 16:33:07 Z

Omnicell Inc. ( OMCL ) reported first-quarter 2013 net operating earnings of 14 cents per share, missing the Zacks Consensus Estimate of 19 cents. Results nevertheless improved 7.7% year

Merge 1Q13: Loss Widens; Meets Est - Analyst Blog

Zacks Equity Research — Thu, 02 May 2013 23:26:05 Z

Merge Healthcare Incorporated ( MRGE ) reported net loss of 7 cents per share in the first quarter of 2013, worse than the year-ago net loss of 2 cents per share. Considering stock-based

DexCom Loss Narrower than Est. - Analyst Blog

Zacks Equity Research — Thu, 02 May 2013 22:26:20 Z

DexCom, Inc. ( DXCM ), a player in the glucose monitoring market, reported first quarter 2013 adjusted loss per share of 16 cents, narrower than the Zacks Consensus Estimate of a loss of 17

Huge Earnings Miss By AMED, Guides Low - Analyst Blog

Zacks Equity Research — Wed, 01 May 2013 23:38:01 Z

Home healthcare provider Amedisys ( AMED ) reported net income of $3.9 million or 9 cents per share in the first quarter of 2013, a considerable slide from net income of $8.6 million or

Fresenius Earnings Lower Y/Y - Analyst Blog

Zacks Equity Research — Wed, 01 May 2013 17:57:23 Z

Dialysis company Fresenius Medical Care ( FMS ) announced first quarter 2013 earnings per ordinary share of 74 cents which was 8% lower than the year-ago adjusted earnings per share of 80

Luminex Beats 1Q Earnings Est. - Analyst Blog

Zacks Equity Research — Wed, 01 May 2013 13:47:17 Z

Luminex Corporation 's ( LMNX ) first-quarter 2013 adjusted earnings per share of 14 cents beat the Zacks Consensus Estimate of 8 cents per share by 75%. It also exceeded the year-ago

Reiterate Varian at Neutral - Analyst Blog

Zacks Equity Research — Tue, 30 Apr 2013 22:50:26 Z

On Apr 29, we retained Varian Medical Systems, Inc. ( VAR ) at Neutral after the company reported results for the second quarter fiscal 2013. Why the Reiteration? On April 24, Varian

ResMed's Earnings Beat; Revs Lag - Analyst Blog

Zacks Equity Research — Mon, 29 Apr 2013 22:50:33 Z

ResMed Inc. (RMD) posted adjusted earnings per share (EPS) of 59 cents in the third quarter of fiscal 2013, edging past the Zacks Consensus Estimate by a couple of cents. The results were also